Walleye Trading’s iRadimed IRMD Stock Holding History

Walleye Trading’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-100	Closed	-$4K	–	4955
2018 Q3	$4K	Buy	+100	New	+$2.7K	﹤0.01%	5140
2015 Q4	–	Sell	-300	Closed	-$7K	–	5460
2015 Q3	$7K	Buy	+300	New	+$7.18K	﹤0.01%	4512

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return

CCM

Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Walleye Trading's IRMD Position: Q4 2018 in Review

Walleye Trading sold out of iRadimed (IRMD) in Q4 2018, closing a stake of 100 shares — an estimated $4K sold.

Walleye Trading first reported a position in IRMD in Q3 2015 and held it in 2 quarters. The position peaked at $7K in Q3 2015. 67 funds tracked by Wall St. Rank hold IRMD as of Q4 2018.

Walleye Trading reported no remaining iRadimed position as of Q4 2018 after selling out during the quarter.
Walleye Trading sold 100 iRadimed shares in Q4 2018, an estimated $4K.
Walleye Trading first reported a position in iRadimed in Q3 2015 and held it in 2 quarters.
Walleye Trading's iRadimed position peaked at $7K in Q3 2015.
67 funds tracked by Wall St. Rank held iRadimed as of Q4 2018.

Based on Walleye Trading's 13F filing for Q4 2018, filed 14 Feb 2019.